IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
Saved in:
| Title: | IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex. |
|---|---|
| Authors: | Valvezan AJ; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., McNamara MC; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Miller SK; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Torrence ME; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Henske EP; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Manning BD; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. |
| Source: | JCI insight [JCI Insight] 2020 Apr 09; Vol. 5 (7). Date of Electronic Publication: 2020 Apr 09. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
